Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 7—July 2013
Research

Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel

Daniel M. WeinbergerComments to Author , Noga Givon-Lavi, Yonat Shemer-Avni, Jacob Bar-Ziv, Wladimir J. Alonso, David Greenberg, and Ron Dagan
Author affiliations: Yale School of Public Health, New Haven, Connecticut, USA (D.M. Weinberger); National Institutes of Health, Bethesda, Maryland, USA (D.M. Weinberger, W.J. Alonso); Soroka University Medical Center, Beer-Sheva, Israel (N. Givon-Lavi, Y. Shemer-Avni, D. Greenberg); Ben-Gurion University of the Negev, Beer-Sheva (N. Givon-Lavi, Y. Shemer-Avni, D. Greenberg, R. Dagan); Hadassah University Medical Center, Jerusalem, Israel (J. Bar-Ziv)

Main Article

Table 2

Impact of pneumococcal conjugate vaccine from different models, southern Israel*

Age group, mo. Fit to 2004–05 through 2011–12
 Fit to 2004–05 through 2010–11 (excluding 2011–12)
Full model Model without RSV† Unadjusted‡ Full model Model without RSV† Unadjusted‡
<6 −31.5 (−50.6 to −14.5) −30.7 (−57.2 to 9.7) −20.0 (−70.2 to 76.5) −27.9 (−62.9 to 9.2) −5.2 (−68.5 to 83.9) +22.3 (−81.5 to +106.0)
6–17 −40.5 (−52.1 to −31.5) −39.6 (−52.7 to −26.0) −36.0 (−63.4 to 4.6) −36.3 (−53.6 to −19.7) −29.9 (−53.7 to –7.8) −20.0 (−69.5 to +44.0)
17–35 −33.6 (−41.5 to −25) −33.0 (−40.9 tp −23.1) −31.3 (−47.8 to −8.4) −33.3 (−45.0 to −16.0) −29.1 (−44.2 to –10.8) −25.4 (−55.0 to +11.1)

*Vaccine impact is the estimated percentage change in disease incidence associated with pneumococcal conjugate vaccine use. RSV, respiratory syncytial virus.
†Model fit with all predictors described in the methods section except for RSV activity.
‡Model fit with predictors for vaccine uptake and ethnicity only.

Main Article

Page created: June 17, 2013
Page updated: June 17, 2013
Page reviewed: June 17, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external